Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Imbruvica

Home/Tag:Imbruvica
8 12, 2015

More drugs are good, but aren’t enough

Tags: , , , , , |9 Comments

Data for more than a dozen "new" myeloma drugs was presented at this week's American Society of Hematology (ASH) meetings here in Orlando. As I described yesterday, several are hopeful crossover drugs; compounds that are already FDA approved for use against other cancers. Keytruda, known chemically as pembrolizumab, and ricolinostat (ACY-1215), another possible cross over

4 12, 2015

Has bad timing left ASH irrelevant?

Tags: , , |2 Comments

I'm almost packed. Tomorrow I'll be driving three hours south to Orlando to attend my 7th American Society of Hematology (ASH) annual meeting. Seven years! How the multiple myeloma therapy landscape has changed. Heck, things have been turned upside down in three short weeks. The Washington Post ran an impressive article about it on Wednesday: